Explore compound 
Growth research
Ipamorelin
10 mg / $75.00
Ipamorelin is a synthetic pentapeptide growth-hormone secretagogue derived from the GHRP series, incorporating non-proteinogenic residues and a C-terminal amide.
Available formats
Availability and final pricing are checked at checkout.
1 laboratory report availableFor laboratory research use only. Not for human consumption.
A closer look
The details
behind the compound.
Overview
Ipamorelin is a synthetic pentapeptide growth-hormone secretagogue derived from the GHRP series, incorporating non-proteinogenic residues and a C-terminal amide. Developed at Novo Nordisk, it was the first secretagogue characterized for its selectivity of growth-hormone release.
It is valued in the laboratory for its well-defined receptor selectivity and is frequently paired with releasing-hormone analogs in comparative endocrine study.
- Molecular formula
- C38H49N9O5
- Molecular weight
- 711.9 g/mol
- CAS number
- 170851-70-4
Laboratory documentation
Check the product format and report identifiers before comparing results. Available reports do not establish the lot currently held in stock.
Vanguard LaboratoryAnalysis report · Lot I26C23498.58%Research references
Raun K, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998.
Gobburu JVS, et al. Pharmacokinetic-pharmacodynamic modeling of ipamorelin in human volunteers. Pharm Res. 1999.
Storage & handling
Store the lyophilized peptide at −18°C to −20°C, where it is stable for extended periods. Reconstituted solution is held refrigerated near 4°C for a few weeks; protect from light.

